Skip to main content
. 2023 Aug 31;109(4):1171–1183. doi: 10.3324/haematol.2023.283352

Figure 1.

Figure 1.

Patients with tumors with MYChigh protein overexpression have a worse outcome than patients with MYClow tumors. (A, B) Prognostic impact of MYC protein expression on overall survival (A) and progression-free survival (B). Samples (N=252) were categorized based on total percentage of MYC-expressing cells, with a cutoff of 20%. Kaplan-Meier estimates were calculated and are shown. Log-rank statistics were used to evaluate the statistical significance. PFS: progression-free survival.